Member Exclusive News

The week in industry: First-in-class psoriasis treatment approved in China

This week: Lonza and Chr Hansen aim to position themselves as leaders in the live biotherapeutic product industry, the US FDA approves an IND application for the first allogeneic CAR-T to treat multiple myeloma patients and report shows 17 innovative sickle cell medicines are in development.

Thumb untitled design
Apr 04, 2019

Please sign in or register for FREE

No comments yet.